Stay updated on Nivolumab with 5-azacytidine in Childhood AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:27:52.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change likely represents an update in the phase I/II study of Nivolumab in Combination with 5-azacytidine in pediatric patients with relapsed/refractory acute myeloid leukemia, specifically related to the assessment of the clinical activity of Nivolumab in combination with 5-azacytidine in AML patients with M2/M3 disease at study entry.
    Difference
    0.1%
    Check dated 2024-06-06T14:33:51.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has updated the 'Participation Criteria' section to provide detailed eligibility criteria for participants, including age, diagnosis, and prior treatments, replacing the previous generic statement. This change offers specific inclusion and exclusion criteria for the clinical study on relapsed or refractory AML in pediatric patients.
    Difference
    52%
    Check dated 2024-05-22T20:28:43.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:56:48.000Z thumbnail image

Stay in the know with updates to Nivolumab with 5-azacytidine in Childhood AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.